Accrued Expenses

3 Months Ended

Mar. 31, 2025

Accrued Expenses

Accrued Expenses

Note 3. Accrued Expenses

The following is a summary of the Company’s accrued expenses:

	March 31,		December 31,
	2025		2024
Clinical trial expenses	$	1,388,546	$	1,135,542
Other		2,015,786		1,223,797
Total	$	3,404,332	$	2,359,339